text
stringlengths
0
5.79k
WSI and its corresponding RoIs. All the RoIs were extracted and annotated with the help of QuPath17 . The number of extracted
RoIs per WSI ranges from 0 to 119, with an average of 11 RoIs per WSI. Multiple RoIs corresponding to different lesion
subtypes were selected per WSI such that the collected RoIs across all WSIs collectively encompass the lesion heterogeneity.
This aspect is very crucial for representing pathogenesis and disease progression, and consequently allowing for the inclusion
of sufficiently variable data for DL model training. Subsequently, the WSI-level labels were trivially defined as the most
aggressive tumor subtype annotated in the image.
Subtype annotations
An important characteristics of BRACS is the inclusion of atypical lesions, ADH and FEA. While ignored in other public
datasets, these categories remain important as they might be indicators of either (i) the presence of abnormalities in neighboring
breast tissue that could go undetected, e.g., due to the extraction of small tissue samples, or (ii) a high risk of onset of future
carcinoma, i.e., development of DCIS and IC. In addition, these lesions cannot be detected by mammography or other breast
imaging techniques, nor can they be felt during a clinical breast examination. When detected in a core biopsy, more frequent
imaging follow-up and often surgical excision are recommended18 . BRACS also includes lesion subtypes belonging to benign
and malignant types. In particular, benign lesions are subtyped as either non-cancerous lesions (PB) or inflammatory responses
2/10
Figure 1. Example of a WSI and its associated RoIs. The color of each contour indicates the tumor subtype of the lesion
according to a fixed color palette.
(UDH). Malignant lesions are categorized as either DCIS or IC. Finally, histology images representing normal tissue sample are
classified in the Normal (N) category.
In order to clarify the description of the different tissue subtypes, a brief description of the mammary gland should be
considered. The breast is a modified apocrine sweat gland, made up of 15-25 independent glandular units called lobes, each of
which is formed by a compound tubulo-acinar gland. The lobes are comprised of adipose tissue and divided by connective
tissue septa. Inside each lobe, the main ducts branch into terminal ducts, each of which leads to a lobule that is made up of
many berries to form the ductulo-lobular terminal unit. Detailed information on lesions included in BRACS can be found
in19 . The specific features of the different sample tissue subtypes are shortly summarized in the following and a representative
example for each of them is shown in Figure 2.
Normal Tissue (N)
In normal mammary glandular tissue, there are two types of epithelial cells (the luminal layer and the basal myoepithelial layer)
and two types of stromal cells (interlobular stroma and intralobular stroma). Differently from PB, the ratio between epytelial
component and stroma is preserved.
Pathological Benign (PB)
Benign breast lesions can be grouped according to the risk of developing invasive carcinoma and include several groups
of histological entities classified in relation to morphology. In our study, for reasons of differential diagnosis, in the PB
category we included both non-proliferative lesions and proliferative lesions with the exception of UDH, FEA and ADH, which
were considered as three independent subtypes. Therefore, PB includes cyst, apocrine metaplasia, ductal ectasia, squamous
metaplasia, atrophy, stromal fibrosis, mastitis, sclerosing adenosis, papilloma, radial scar, simple and complex fibroadenoma.
Usual Ductal Hyperplasia (UDH)
UDH is characterized by an increase in the epithelial layers. It is a cohesive proliferation of disorderly distributed but oriented
cells. It can have different architectural aspects (solid pattern, fenestrated pattern, micropapillary pattern). Even if UDH shares
some architectural features with ADH and DCIS, it does not show atypia.
Flat Epithelial Atypia (FEA)
FEA is a proliferative lesion characterized by low grade cytological atypia, cell monomorphism, loss of polarity and orientation
with respect to the basement membrane, presence of apical snout, endoluminal secretion and frequent calcifications.
Atypical Ductal Hyperplasia (ADH)
ADH is a proliferation of monomorphic cells, which only partially fill the ductal spaces. Architectural aspects include a solid
pattern, a cribriform pattern and a papillary pattern. The cytologic atypia is similar to that of low-grade DCIS, but the lesion
3/10
(a) (b) (c)
(d) (e)
(f) (g)
Figure 2. Examples of different tissue samples: (a) Normal (N), (b) Pathological Benign (PB), (c) Usual Ductal Hyperplasia
(UDH), (d) Flat Epithelial Atypia (FEA), (e) Atypical Ductal Hyperplasia (ADH), (f) Carcinoma in Situ (DCIS) and (g)
Invasive Carcinoma (IC).
4/10
spans no more than 2mm or has an insufficient architectural atypia involving only partially ducts and / or lobules.
Ductal Carcinoma in Situ (DCIS)
In situ carcinoma is a malignant proliferation of epithelial cells that fills the entire duct, without evidence of stroma invasion.
Typically it involves multiple adjacent ductal spaces. It can have cribriform, solid, papillary and micropapillary patterns.
Invasive Carcinoma (IC)
IC is characterized by the invasion of tumor cells infiltrating the breast stroma with loss of peripheral myoepithelial cells. The
presence of the myoepithelial cell layer is an important distinction of DCIS from IC.
Detecting certain subtypes is particularly challenging as some morphological patterns can be shared by several classes. For
instance, ADH shares morphological similarities with DCIS. In certain cases, it even includes all the features of DCIS, but is
simply limited in size. Also, UDH, ADH and DCIS are all characterized by an intraductal growth pattern, which makes these
classes difficult to classify and differentiate in H&E-stained sections. This is particularly true when pathologists cannot utilize
significant WSI-level context. We emphasize that when classifying BRACS RoIs, no context information is provided beside the
tissue lesion and immediate tissue micro-environment.
BRACS dataset characteristics
The BRACS dataset contains 547 WSIs extracted on 189 different patients. It also includes 4’539 RoIs extracted from 387 WSI
collected on 151 patients. All slides were scanned with an Aperio AT2 scanner at 0.25 µm/pixel using a magnification factor
of 40×. Table 1 and Table 2 report the number of WSIs (with and without RoIs) and RoIs according to the lesion type and
subtypes, respectively.